tiprankstipranks
Advertisement
Advertisement

CBIO Stock Latest News

Crescent Biopharma 8.095M share Spot Secondary priced at $14.50
The FlyCrescent Biopharma 8.095M share Spot Secondary priced at $14.50
6d ago
CBIO
Crescent Biopharma files ordinary shares offering, no amount given
PremiumThe Fly
Crescent Biopharma files ordinary shares offering, no amount given
7d ago
CBIO
BTIG says others may be interested in Apogee Therapeutics
PremiumThe Fly
BTIG says others may be interested in Apogee Therapeutics
29d ago
JNJ
NVS
Campbell, Crescent, Cardiff, Sherwin, Take-Two Trending With Analysts
PremiumWeekend Updates
Campbell, Crescent, Cardiff, Sherwin, Take-Two Trending With Analysts
2M ago
CPB
SHW
Crescent Biopharma shareholders back directors, pay and auditor
PremiumCompany Announcements
Crescent Biopharma shareholders back directors, pay and auditor
2M ago
8K
CBIO
Crescent Biopharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyCrescent Biopharma downgraded to Neutral from Buy at H.C. Wainwright
2M ago
CBIO
Crescent Biopharma reports Q1 EPS (70c), consensus (79c)
Premium
The Fly
Crescent Biopharma reports Q1 EPS (70c), consensus (79c)
3M ago
CBIO
Crescent Biopharma management to meet with Cantor Fitzgerald
Premium
The Fly
Crescent Biopharma management to meet with Cantor Fitzgerald
3M ago
CBIO
Crescent Biopharma price target lowered to $22 from $25 at H.C. Wainwright
PremiumThe Fly
Crescent Biopharma price target lowered to $22 from $25 at H.C. Wainwright
5M ago
CBIO
Crescent Biopharma reports Q4 EPS ($4.01) vs. ($19.74) last year
PremiumThe Fly
Crescent Biopharma reports Q4 EPS ($4.01) vs. ($19.74) last year
5M ago
CBIO
Crescent Biopharma sees cash runway into 2028
PremiumThe Fly
Crescent Biopharma sees cash runway into 2028
5M ago
CBIO
3 ‘Strong Buy’ Stocks to Buy Now, 2/19/2026, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Now, 2/19/2026, According to Top Analysts
5M ago
CBIO
CHWY
Crescent Biopharma announces grants of inducement awards
PremiumThe FlyCrescent Biopharma announces grants of inducement awards
5M ago
CBIO
Crescent Biopharma: Fast-Follower Potential of CR-001 and Strategic Partnerships Support Buy Rating and $25 Target
Premium
Ratings
Crescent Biopharma: Fast-Follower Potential of CR-001 and Strategic Partnerships Support Buy Rating and $25 Target
5M ago
CBIO
Crescent Biopharma announces first patient dosed in ASCENT Phase 1/2 trial
Premium
The Fly
Crescent Biopharma announces first patient dosed in ASCENT Phase 1/2 trial
5M ago
CBIO
Crescent Biopharma initiated with an Overweight at Piper Sandler
PremiumThe Fly
Crescent Biopharma initiated with an Overweight at Piper Sandler
6M ago
CBIO
Crescent Biopharma initiated with a Buy at Guggenheim
PremiumThe Fly
Crescent Biopharma initiated with a Buy at Guggenheim
6M ago
CBIO
SMMT
Crescent Biopharma Advances CR-001 Cancer Trial Into First-in-Human Stage
PremiumCompany Announcements
Crescent Biopharma Advances CR-001 Cancer Trial Into First-in-Human Stage
6M ago
CBIO
Crescent Biopharma files to sell 19.71M shares of common stock for holders
PremiumThe Fly
Crescent Biopharma files to sell 19.71M shares of common stock for holders
6M ago
CBIO
Crescent Biopharma: Advancing De-Risked Immuno-Oncology Pipeline and Strategic Partnerships Underscore Undervalued Buy Opportunity
PremiumRatingsCrescent Biopharma: Advancing De-Risked Immuno-Oncology Pipeline and Strategic Partnerships Underscore Undervalued Buy Opportunity
7M ago
CBIO
Crescent Biopharma announces regulatory clearance of IND applications
Premium
The Fly
Crescent Biopharma announces regulatory clearance of IND applications
7M ago
CBIO
Two new option listings and eighteen option delistings on December 22nd
Premium
The Fly
Two new option listings and eighteen option delistings on December 22nd
7M ago
QD
EPS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >